| Market Cap | ₹61,352Cr |
| ROE | 37.62% |
| P/E Ratio(TTM) | 40.66 |
| EPS(TTM) | 710.09 |
| P/B Ratio | 15.30 |
| Dividend Yield | 1.65% |
| Industry P/E | 39.95 |
| Book Value | 1887.49 |
| Debt to Equity | 0.05 |
| Face Value | 10 |
| Parent Organisation | Abbott India Limited |
| Managing Director | Mr. Vivek Kamath |
| Founded | 1944 |
| NSE Symbol | ABBOTINDIA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 43.71 | ||
| Pfizer | NA (0.00%) | 27.52 | ||
| Astrazeneca Pharma India | NA (0.00%) | 111.83 | ||
| Sanofi Consumer Healthcare India | NA (0.00%) | 47.16 |